Senior insider sale
SVP, Chief Financial Officer at SANA BIOTECHNOLOGY, INC. — senior position signals high conviction
$245.8K
71.73K shares
What this filing means
HARDY NATHAN plans to sell 71.73K shares of SANA BIOTECHNOLOGY, INC. valued at approximately $245.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/25/2024ACC: 0001950047-24-009115
Officer· SVP, Chief Financial Officer
Since Feb 2021
71.73K
Shares to sell
$245.8K
Approx. market value
25.93K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founder Stock
Cash
7/23/2019
25.93KTotal acquired25.93K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/23/2019 | Founder Stock Cash | 25.93K | — |
| Total | 25.93K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
45.80K
Market value
$180.8K
10/21/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.93K
Market value
$65.0K
11/25/2024
Total
Units
71.73K
Value
$245.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/21/2024 | 45.80K | $180.8K | — | Completed |
| Planned — Approximate Date | ||||
11/25/2024 | 25.93K | $65.0K | NASDAQ | Planned |
| Total | 71.73K | $245.8K | ||